Log In
BCIQ
Print this Print this
 

ATX-MS2

  Manage Alerts
Collapse Summary General Information
Company Apitope International N.V.
DescriptionNot disclosed
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentDiscovery
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat multiple sclerosis (MS)
Regulatory Designation
PartnerMerck KGaA

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today